We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$574M
AUM Growth
+$51.8M
Cap. Flow
+$390K
Cap. Flow %
0.07%
Top 10 Hldgs %
50.16%
Holding
79
New
7
Increased
29
Reduced
31
Closed
1

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.05M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$837K
3
RTX icon
RTX Corp
RTX
+$826K
4
MNST icon
Monster Beverage
MNST
+$807K
5
V icon
Visa
V
+$635K

Top Sells

Rank Stock Value
1
PAYX icon
Paychex
PAYX
+$2.77M
2
AAPL icon
Apple
AAPL
+$2.05M
3
NVDA icon
NVIDIA
NVDA
+$583K
4
ADP icon
Automatic Data Processing
ADP
+$361K
5
MCD icon
McDonald's
MCD
+$256K

Sector Composition

Rank Sector Weight
1 Technology 29.6%
2 Healthcare 19.13%
3 Communication Services 12.43%
4 Consumer Discretionary 11.43%
5 Financials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
26
Constellation Brands
STZ
$22.2B
$7.93M 1.38%
31,585
+581
+2% +$132K
RTX icon
27
RTX Corp
RTX
$290B
$7.75M 1.35%
90,081
+9,479
+12% +$826K
REGN icon
28
Regeneron Pharmaceuticals
REGN
$78.5B
$5.83M 1.02%
9,218
+1,362
+17% +$837K
ISRG icon
29
Intuitive Surgical
ISRG
$127B
$5.74M 1%
15,975
-45
-0.3% -$15.5K
JNJ icon
30
Johnson & Johnson
JNJ
$618B
$5.55M 0.97%
32,463
+84
+0.3% +$13.8K
HD icon
31
Home Depot
HD
$331B
$5.3M 0.92%
12,777
-23
-0.2% -$8.76K
CL icon
32
Colgate-Palmolive
CL
$73.1B
$4.83M 0.84%
56,821
-1,134
-2% -$88.6K
CRM icon
33
Salesforce
CRM
$151B
$4.19M 0.73%
16,480
+225
+1% +$63.2K
MSFT icon
34
Microsoft
MSFT
$3.45T
$4.1M 0.71%
12,193
+315
+3% +$102K
MCD icon
35
McDonald's
MCD
$192B
$4.03M 0.7%
15,019
-1,013
-6% -$256K
PG icon
36
Procter & Gamble
PG
$336B
$3.82M 0.67%
23,297
-30
-0.1% -$4.45K
AMT icon
37
American Tower
AMT
$80.8B
$3.39M 0.59%
11,606
-29
-0.2% -$7.92K
JPM icon
38
JPMorgan Chase
JPM
$935B
$2.99M 0.52%
18,931
+118
+0.6% +$19.4K
DEO icon
39
Diageo
DEO
$49B
$2.54M 0.44%
11,535
-10
-0.1% -$2.05K
SYY icon
40
Sysco
SYY
$40.8B
$2.25M 0.39%
28,496
-280
-1% -$21.6K
HON icon
41
Honeywell
HON
$77B
$2.09M 0.36%
10,614
+1,603
+18% +$324K
NEE icon
42
NextEra Energy
NEE
$181B
$1.83M 0.32%
19,635
+435
+2% +$37.6K
MDLZ icon
43
Mondelez International
MDLZ
$79.5B
$1.81M 0.31%
27,386
+850
+3% +$52.5K
QCOM icon
44
Qualcomm
QCOM
$155B
$1.78M 0.31%
9,720
-115
-1% -$18.4K
ABBV icon
45
AbbVie
ABBV
$443B
$1.7M 0.3%
12,616
-173
-1% -$20.4K
ADBE icon
46
Adobe
ADBE
$99.5B
$1.2M 0.21%
2,109
WMT icon
47
Walmart Inc
WMT
$885B
$1.17M 0.2%
24,135
-435
-2% -$20.8K
MNST icon
48
Monster Beverage
MNST
$94.3B
$872K 0.15%
+18,160
New +$807K
CMCSA icon
49
Comcast
CMCSA
$85B
$761K 0.13%
15,213
+2,747
+22% +$143K
NVS icon
50
Novartis
NVS
$297B
$735K 0.13%
8,449

Similar funds

Dillon & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Dillon & Associates held 79 positions worth $574M, up 9.9% from $522M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Dillon & Associates's Q4 2021 filing shows 7 new, 29 increased, 31 reduced and 1 closed positions. Its largest new stake was Monster Beverage: 18,160 shares worth $872K. The largest sale was Paychex, an estimated $2.77M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Dillon & Associates's largest Q4 2021 buy was Monster Beverage: 18,160 shares worth $872K.
  • Dillon & Associates added most to PayPal in Q4 2021, an estimated $1.05M increase.
  • Dillon & Associates's biggest Q4 2021 reduction was Paychex, cutting an estimated $2.77M.
  • Dillon & Associates fully exited Walgreens Boots Alliance in Q4 2021, selling an estimated $247K.
  • Dillon & Associates's ten largest holdings make up 50% of its $574M portfolio in Q4 2021.
  • Dillon & Associates opened 7 new positions and closed 1 in Q4 2021.
  • Dillon & Associates's portfolio value rose 9.9% quarter-over-quarter to $574M.

Based on Dillon & Associates's 13F filing for Q4 2021, filed 14 Feb 2022.